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Objective
In our previous experiments decreased adaptability in rats
exposed to perinatal morphine (MO) was observed 2 days
after weaning. The aim of the present study was to exam-
ine how chronic MO treatment of dams influences the
maternal behaviour (MB) and the sensitivity toward MO
in offspring.
Methods
Pregnant Wistar rats were treated daily with MO (10 mg/
kg s.c.) from the day of mating until weaning (post par-
tum day [PD] 21). Spontaneous MB (active nursing, pas-
sive nursing, littering and behaviours out of the nest) was
checked on the 2nd, 3rd, 5th, 7th and 9th PDs. Analgesic
affect of MO was measured in tail-flick test in the offspring
on PD 23. Conditioned place preference (CPP) inducing
effect of MO was checked in adult offspring.
Results
(1) Chronic MO treatment significantly impaired the MB.
(2) Analgesic effect of MO was less marked, the CPP-
inducing effect of MO, however, was more marked in off-
spring.
Conclusion
Perinatal MO exposure alters the MO sensitivity in the off-
spring. The enhanced sensitivity to the reinforcing effect
of MO in CPP, however, may be the consequence of
altered maternal behaviour, too.
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